Clinical Trials Browser

Developmental Disabilities, Communication Disorders, Deglutition Disorders, Head and Neck Neoplasms, Language Development Disorders, Language Disorders, Speech, Stuttering, Hearing Loss

NCT01864291 2020-06-02

ABI

Phase NA Terminated

9 enrolled 10 charts

Deafness, Hearing Loss

NCT01736267 2020-05-06

Auditory Brainstem Implant (ABI) in Adult Non-Neurofibromatosis Type 2 Subjects

Phase NA Terminated

3 enrolled 8 charts

Deafness, Hearing Loss

NCT01969370 2017-05-03

NCGENES

Phase NA Completed

645 enrolled

Congenital Abnormalities, Cardiovascular Diseases, Neoplasms, Neurologic Manifestations, Neurodegenerative Diseases, Hearing Loss

NCT00584155 2015-05-27

Protection From Cisplatin Ototoxicity by Lactated Ringers

Phase 1 Withdrawn

Ear Neoplasms, Hearing Loss

Clinical Trials

Assessment of Patient Experience With Auto-Captioning Glasses in NF2-Related-Schwannomatosis

Ph. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS)

Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors

Head and Neck Cancer Survivorship Ototoxicity Screening (SOS)

Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors

Auditory Brainstem Implant (ABI) in Children With No Cochleae or Auditory Nerves

HEAR

HSA50+

SSNHL in Head & Neck Cancer Patients

MRI-based Synthetic CT Images of the Head and Neck

Intratympanic N-Acetylcysteine for Prevention of Cisplatin-induced Ototoxicity.

NAC to Prevent Cisplatin-induced Hearing Loss

Providing Speech Therapy Awareness in Private Schools

ABI

Auditory Brainstem Implant (ABI) in Adult Non-Neurofibromatosis Type 2 Subjects

NCGENES

Protection From Cisplatin Ototoxicity by Lactated Ringers